Folgen
Christoph Buchta
Christoph Buchta
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei oequasta.at
Titel
Zitiert von
Zitiert von
Jahr
Platelet content and growth factor release in platelet‐rich plasma: a comparison of four different systems
GC Leitner, R Gruber, J Neumüller, A Wagner, P Kloimstein, P Höcker, ...
Vox sanguinis 91 (2), 135-139, 2006
2872006
Anti‐D immunization by DEL red blood cells
T Wagner, GF Körmöczi, C Buchta, M Vadon, G Lanzer, WR Mayr, ...
Transfusion 45 (4), 520-526, 2005
2732005
Biochemical characterization of autologous fibrin sealants produced by CryoSeal® and Vivostat® in comparison to the homologous fibrin sealant product Tissucol/Tisseel®
C Buchta, HC Hedrich, M Macher, P Höcker, H Redl
Biomaterials 26 (31), 6233-6241, 2005
1842005
Influence of clinical factors on the haemolysis marker haptoglobin
GF Körmöczi, MD Säemann, C Buchta, M Peck‐Radosavljevic, WR Mayr, ...
European journal of clinical investigation 36 (3), 202-209, 2006
1012006
Reduction of adverse citrate reactions during autologous large‐volume PBPC apheresis by continuous infusion of calcium‐gluconate
C Buchta, M Macher, C Bieglmayer, P Höcker, M Dettke
Transfusion 43 (11), 1615-1621, 2003
852003
Stability of coagulation factors in thawed, solvent/detergent‐treated plasma during storage at 4° C for 6 days
C Buchta, M Felfernig, P Höcker, M Macher, GF Körmöczi, ...
Vox sanguinis 87 (3), 182-186, 2004
822004
Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR
C Buchta, I Görzer, P Chiba, JV Camp, H Holzmann, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 59 (5), 987-994, 2021
622021
Fibrin sealant produced by the CryoSeal® FS system: product chemistry, material properties and possible preparation in the autologous preoperative setting
C Buchta, M Dettke, PT Funovics, P Höcker, P Knöbl, M Macher, ...
Vox sanguinis 86 (4), 257-262, 2004
612004
Application of platelet-rich plasma for enhanced bone regeneration in grafted sinus
PW Poeschl, F Ziya-Ghazvini, K Schicho, C Buchta, D Moser, R Seemann, ...
Journal of oral and maxillofacial surgery 70 (3), 657-664, 2012
592012
EurA1c: the European HbA1c trial to investigate the performance of HbA1c assays in 2166 laboratories across 17 countries and 24 manufacturers by use of the IFCC model for …
Clinical chemistry 64 (8), 1183-1192, 2018
522018
Transfusion‐related exposure to the plasticizer di (2‐ethylhexyl) phthalate in patients receiving plateletpheresis concentrates
C Buchta, C Bittner, H Heinzl, P Höcker, M Macher, M Mayerhofer, ...
Transfusion 45 (5), 798-802, 2005
422005
Donor exposure to the plasticizer di (2‐ethylhexyl) phthalate during plateletpheresis
C Buchta, C Bittner, P Höcker, M Macher, R Schmid, C Seger, M Dettke
Transfusion 43 (8), 1115-1120, 2003
412003
CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia
HJ Ankersmit, GA Roth, B Moser, A Zuckermann, M Brunner, C Rosin, ...
American Journal of Transplantation 3 (6), 754-759, 2003
292003
Short and long term effects of citrate on bone metabolism and bone mineral density in healthy plateletpheresis donors
M Dettke, C Buchta, C Bieglmayer, F Kainberger, M Macher, P Hocker
J Clin Apher 18 (14), 87-88, 2003
262003
RT-PCR based SARS-CoV-2 variant screening assays require careful quality control
JV Camp, C Buchta, J Jovanovic, E Puchhammer-Stöckl, B Benka, ...
Journal of Clinical Virology 141, 104905, 2021
222021
Mosaicism due to myeloid lineage–restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting
GF Körmöczi, EM Dauber, OA Haas, TJ Legler, FB Clausen, G Fritsch, ...
Blood, The Journal of the American Society of Hematology 110 (6), 2148-2157, 2007
222007
Should DEHP be eliminated in blood bags?
PF Van Der Meer, HW Reésink, S Panzer, J Wong, S Ismay, A Keller, ...
Vox Sanguinis 106 (2), 176-195, 2014
212014
Evidence for the positive impact of ISO 9001 and ISO 15189 quality systems on laboratory performance–evaluation of immunohaematology external quality assessment results during …
C Buchta, W Coucke, WR Mayr, MM Müller, R Oeser, CR Schweiger, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 56 (12), 2039-2046, 2018
202018
Presentation and formatting of laboratory results: a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group …
J Cadamuro, A Hillarp, A Unger, A von Meyer, JM Bauca, O Plekhanova, ...
Critical reviews in clinical laboratory sciences 58 (5), 329-353, 2021
192021
The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria
C Buchta, JV Camp, J Jovanovic, P Chiba, E Puchhammer-Stöckl, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 59 (10), 1735-1744, 2021
182021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20